Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
antiviral agents
asymptomatic
compliance
complications
highly active antiretroviral therapy
human immunodeficiency virus type 1
human immunodeficiency virus type 1, prophylaxis
preexposure prophylaxis
prevention of neurologic disorders
safety
sexually transmitted disease
treatment of neurologic disorder
viral infection
Showing articles 850 to 900 of 3083 << Previous Next >>

Therapeutic Hypothermia for Global and Focal Ischemic Brain Injury-A Cool Way to Improve Neurologic Outcomes
Neurologist 13:331-342, Hoesch,R.E. &Geocadin,R., 2007

Randomized Trial of IV Dexamethasone for Acute Migraine in the Emergency Department
Neurol 69:2038-2044, Friedmna,B.W.,et al, 2007

Randomized Study of Intravenous Valproate and Phenytoin in Status Epilepticus
Seizure 16:527-532, Agarwal,P.,et al, 2007

Intravenous Sodium Valproate Versus Diazepam Infusion for the Control of Refractory Status Epilepticus in Children: A Randomized Controlled Trial
J Child Neurol 22:1191-1197, Mehta,V.,et al, 2007

Subarachnoid Haemorrhage
Lancet 369:306-318, van Gijn,J.,et al, 2007

Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007

Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007

Tiagabine-Induced Myoclonic Status Epilepticus in a Nonepileptic Patient
Neurol 68:310, Vollmar,C. &Noachtar,S., 2007

Fulminant Idiopathic Intracranial Hypertension
Neurol 68:229-232, Thambisetty,M.,et al, 2007

Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
Stroke 38:874-880, Akins,P.T.,et al, 2007

Febrile Seizures
BMJ 334:307-11, Sadleir,L.G. &Scheffer,I.E., 2007

Sexual Function in Men and Women With Neurological Disorders
Lancet 369:512-525, Rees,P.M.,et al, 2007

Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007

Wernicke Encephalopathy After Obesity Surgery: A Systematic Review
Neurol 68:807-811, Singh,S. &Kumar,A., 2007

Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis
JAMA 297:1344-1353,1376, Crouse III,J.R.,et al, 2007

The SANAD Study of Effectiveness of Carbamazepine,Gabapentin,Lamotrigine,Oxcarbazepine,or Topiramate for Treatment of Partial Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1000-1015, Marson,A.G.,et al, 2007

The SANAD Study of Effectiveness of Valproate,Lamotrigine,or Topiramate for Generalised and Unclassifiable Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1016-1026, Marson,A.G.,et al, 2007

Treatment of Medically Intractable Cluster Headache by Occipital Nerve Stimulation: Long-Term Follow-Up of Eight Patients
Lancet 369:1099-1065, Burns,B.,et al, 2007

Sumatriptan-Naproxen for Acute Treatment of Migraine, A Randomized Trial
JAMA 297:1443-1454, Brandes,J.L.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy
Neurol 68:1249-1250,1245, Liow,K.,et al, 2007

Vigabatrin Improves Paroxysmal Dystonia in Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 68:1320-1321, Leuzzi,V.,et al, 2007

Clinical Update:Diagnosis and Treatment of Essential Tremor
Lancet 369:1152-1154, Benito-Leon,J&Louis,E.D., 2007

Low Dose Aspirin and Cognitive Function in the Womens Health Study Cognitive Cohort
BMJ 334:987-990,961, Kang,J.H.,et al, 2007

Comparison and Predictors of Rash Associated with 15 Antiepileptic Drugs
Neurol 68:1701-1709, Arif,H.,et al, 2007

Mitoxantrone for Multiple Sclerosis Causing Acute Lymphoblastic Leukemia
Neurol 68:1630-1631, Cartwright,M.S.,et al, 2007

Give Dipyridamole with Aspirin Instead of Aspirin Alone to Prevent Vascular Events After Ischaemic Stroke or TIA
BMJ 334:901, Sudlow,C., 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

Postmarketing Modifications in the Safety Labeling of the New Antiepileptics
Neurol 68:1536-1537, Buck,M.L.,et al, 2007

Hemispherectomy for Intractable Epilepsy in Adults: The First Reported Series
Ann Neurol 61:372-376, McClelland,S. III &Maxwell,R.E., 2007

The Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin for the Prevention of Venous Thromboembolism After Acute Ischaemic Stroke (PREVAIL Study): An Open-Label Randomised Comparison
Lancet 369:1347-1355, Sherman,D.G.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
Stroke 38:1881-1885,1736, Hackam,D.D. &Spence,J.D., 2007

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update
Stroke 38:2001-2023, Broderick,J.,et al, 2007

Short-Term Risk for Stroke Is Doubled in Persons With Newly Treated Type 2 Diabetes Compared With Persons Without Diabetes: A Population-Based Cohort Study
Stroke 38:1739-1743, Jeerakathil,T.,et al, 2007

Epidemic Meningitis, Meningococcaemia, and Neisseria meningitidis
Lancet 369:2196-2210, Stephens,D.S.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Effect of Nationwide Injury Prevention Programme on Serious Spinal Injuries in New Zealand Rugby Union: Ecological Study
BMJ 334:1150-1153,1122, Quarrie,K.L.,et al, 2007

Efficacy of Folic Acid Supplementation in Stroke Prevention: A Meta-Analysis
Lancet 369:1876-1882,1841, Wang,X.,et al, 2007

Post-Transplant Acute Limbic Encephalitis: Clinical Features and Relationship to HHV6
Neurol 69:156-165, Seeley,W.W.,et al, 2007

The Syndrome of Transient Epileptic Amnesia
Ann Neurol 61:587-598, Butler,C.R.,et al, 2007

Reduction in Neural-Tube Defects After Folic Acid Fortification in Canada
NEJM 357:135-142, De Wals,P.,et al, 2007

The Neuroprotective Effects of Caffeine: A Prospective Population Study (the Three City Study)
Neurol 69:536-545, Ritchie,K.,et al, 2007

Effects of Treatments for Symptoms of Painful Diabetic Neuropathy: Systematic Review
BMJ 335:87-90, Wong,M.-C.,et al, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
NEJM 356:664-672, Slotman,B.,et al, 2007

Warfarin Versus Aspirin for Stroke Prevention in an Elderly Community Population With Atrial Fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A Randomised Controlled Trial
Lancet 370:493-503,460, Mant,J.,et al, 2007



Showing articles 850 to 900 of 3083 << Previous Next >>